The Division of Rheumatology and Immunology at Duke University Medical Center was one of the first rheumatology units established in this country and is now widely recognized as one of the most pre-eminent.

Working to Combat Scleroderma

Ankoor Shah, MD, assistant professor of medicine, has also assembled a team of specialists to optimize care in a clinic he runs for scleroderma, a disease that leads to hardening of the skin and severe lung disease. “We have a model of care for lupus that has worked for several years, and so we want to bring that to scleroderma where we have not previously had a dedicated center,” said Shah, who joined the Duke faculty in 2012. He is also building a scleroderma registry and hopes soon to begin banking blood samples for future research. 

View our research efforts

Providing Excellent Patient Care

Robert Keenan, MD, MPH, assistant professor of medicine, heads up a gout clinic as well as two infusion centers—one at Brier Creek in Raleigh and one at Duke Clinic—where gout patients can receive an IV drug that breaks down the uric acid crystals that cause intense pain in the joints. “Duke in general has a strong tradition of caring for those with gout,” Keenan said, noting that the IV drug, Krystexxa, was developed at Duke. “We have a unique perspective, from bench to bedside (or clinic, in this case), that many other institutions do not have.” 

See more patient services

The Duke Division of Rheumatology has a rich history of excellence in all three of our missions—patient care, research, and education. The division continues that tradition of excellence today, with faculty members developing new therapies, offering state-of-the-art care, transforming rheumatology education, and leading national and international organizations. 

With additional faculty members and nurse practitioners, and the opening of a rheumatology and infusion clinic at Brier Creek in Raleigh, the division is improving patient access and refining the management of complex diseases including rheumatoid arthritis, lupus, scleroderma, gout, and others.

As the Clinical Lead for the Division, Megan Clowse, MD, MPH, associate professor of medicine, said, “We are currently recruiting new doctors to Duke rheumatology with the vision of a robust and enthusiastic and happy cohort of physicians addressing the rheumatology diseases of the Triangle and North Carolina, with easily accessible comprehensive rheumatalogic care that is at the level of Duke’s reputation, as well as compassionate, state-of-the-art, and evidence-based.”

Latest News

Friday, January 14, 2022
Friday, September 17, 2021
Tuesday, September 14, 2021
Tuesday, July 27, 2021
Monday, July 26, 2021